The management of gastro-oesophageal reflux disease

被引:8
|
作者
Keung, Charlotte [1 ,2 ]
Hebbard, Geoffrey [2 ]
机构
[1] Launceston Gen Hosp, Launceston, Tas, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
关键词
endoscopy; gastro-oesophageal reflux disease; histamine H2 antagonists; proton pump inhibitors;
D O I
10.18773/austprescr.2016.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
If there are no features of serious disease, suspected gastro-oesophageal reflux disease can be initially managed with a trial of a proton pump inhibitor for 4-8 weeks. This should be taken 30-60 minutes before food for optimal effect. Once symptoms are controlled, attempt to withdraw acid suppression therapy. If symptoms recur, use the minimum dose that controls symptoms. Patients who have severe erosive oesophagitis, scleroderma oesophagus or Barrett's oesophagus require long-term treatment with a proton pump inhibitor. Lifestyle modification strategies can help gastro-oesophageal reflux disease. Weight loss has the strongest evidence for efficacy. Further investigation and a specialist referral are required if there is no response to proton pump inhibitor therapy. Atypical symptoms or signs of serious disease also need investigation.
引用
收藏
页码:6 / 10
页数:5
相关论文
共 50 条
  • [41] Gastro-oesophageal reflux disease and respiratory disease
    Ke, MY
    Xu, WB
    Zhong, X
    Xiao, GH
    Wang, ZF
    Huang, XZ
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 : S237 - S238
  • [42] Gastro-oesophageal reflux
    Patiño, JV
    Maoño, MS
    [J]. REVISTA CLINICA ESPANOLA, 1999, 199 (07): : 415 - 417
  • [43] Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management
    Julieta Argüero
    Daniel Sifrim
    [J]. Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 282 - 293
  • [44] Unsolved problems in the management of patients with gastro-oesophageal reflux disease
    Stanghellini, V
    Cogliandro, R
    Cogliandro, L
    De Giorgio, R
    Barbara, G
    Corinaldesi, R
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (12) : 843 - 848
  • [45] Gastro-oesophageal reflux disease - Impact of guidelines on GP management
    Kirby, Catherine N.
    Piterman, Leon
    Nelson, Mark R.
    Dent, John
    [J]. AUSTRALIAN FAMILY PHYSICIAN, 2008, 37 (1-2) : 73 - 77
  • [46] Secondary oesophageal peristalsis in gastro-oesophageal reflux disease
    Pai, CG
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (01) : 30 - 34
  • [47] Gastric emptying and duodeno-gastro-oesophageal reflux in gastro-oesophageal reflux disease
    Freedman, J
    Grybäck, P
    Lindqvist, M
    Granström, L
    Lagergren, J
    Hellströom, PM
    Jacobsson, H
    Näslund, E
    [J]. DIGESTIVE AND LIVER DISEASE, 2002, 34 (07) : 477 - 483
  • [48] Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey
    Bell, Jane C.
    Schneuer, Francisco J.
    Harrison, Christopher
    Trevena, Lyndal
    Hiscock, Harriet
    Elshaug, Adam G.
    Nassar, Natasha
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2018, 103 (07) : 660 - 664
  • [49] The relevance of acidity measurements in the management of gastro-oesophageal reflux disease
    Dammann, HG
    [J]. TREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE AND HELICOBACTER PYLORI INFECTION, 1998, 20 (02): : 19 - 26
  • [50] Gastro-oesophageal reflux
    Karthik, SV
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2004, 97 (01) : 49 - 49